Curcumin ： Memory Loss
C エビデンス 小規模研究からのエビデンスは限られていますが、いくつかの肯定的なシグナルがあります。Preclinical studies show memory enhancement with curcumin in Alzheimer's models. Human studies show limited but positive trends in working memory, primarily with enhanced bioavailability formulations.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'braincited.com';
const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dmemory\u002Dloss';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
結論
Preclinical studies show memory enhancement with curcumin in Alzheimer's models. Human studies show limited but positive trends in working memory, primarily with enhanced bioavailability formulations.
Key Study Findings
In Vitro
Curcumin Improves Hippocampal Cell Bioenergetics, Redox and Inflammatory Markers, and Synaptic Proteins, Regulating Mitochondrial Calcium …
Dose: None
vs: MitoQ (mitochondrial antioxidant)
Outcome: Hippocampal bioenergetics and calcium homeostasis
効果: None
None
対象集団: C57BL6 mice hippocampal slices (4-6 months old)
Review
Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer's Disease: Insights into Molecular Mechanisms and Therapeutic …
Dose: None
vs: None
Outcome: AD pathology modulation via LLPS and autophagy
効果: None
None
対象集団: Alzheimer's disease (review of mechanisms)
In Vitro
4 weeks
Curcumin-enhanced stem cell exosomes: A novel approach to modulating neuroinflammation and improving cognitive function in …
Dose: 30 ug/body, 4 injections over 30 days
vs: MSC-EXO alone; AD (STZ) rat model
Outcome: Memory and neuroinflammation in AD rats
効果: None
None
対象集団: STZ-induced AD male Wistar rats (250+/-50g)
In Vitro
4 weeks
Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum …
Dose: 100 mg/kg each
vs: AlCl3-induced AD aged mice; individual high-dose
Outcome: Cognitive deficits and neuroprotection
効果: None
None
対象集団: 18-month old male Balb/c mice with AlCl3-induced AD
Review
Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty …
Dose: None
vs: None
Outcome: None
効果: None
None
対象集団: None
Other
8 weeks
Increases in brain catecholamine levels counteract memory deficits and reduces Aβ deposition in 5XFAD male …
Dose: None
vs: Vehicle-treated 5XFAD mice
Outcome: Memory improvement and Aβ deposition in 5XFAD mice
効果: None
None
対象集団: 5XFAD male Alzheimer's disease model mice
Key Statistics
8
研究数
600
参加者数
↔
Mixed
C
グレード
Referenced Papers
European journal of …
2025
10 件の引用
Nutrients
2025
10 件の引用
Experimental gerontology
2025
7 件の引用
Neurotoxicity research
2025
7 件の引用
Food science & …
2025
4 件の引用
Biomedicine & pharmacotherapy …
2025
1 件の引用
Neurochemical research
2025
Degenerative neurological and …
2024
66 件の引用
Scientific reports
2024
42 件の引用
Ageing research reviews
2024
41 件の引用
Chinese medicine
2024
29 件の引用
Ageing research reviews
2024
24 件の引用
Nanoencapsulated Curcumin: Enhanced Efficacy in Reversing Memory Loss in An Alzheimer Disease Model.
Other
Brain sciences
2024
14 件の引用
Molecules (Basel, Switzerland)
2024
13 件の引用
Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease.
Review
Mini reviews in …
2024
9 件の引用
Pharmaceutical nanotechnology
2024
2 件の引用
Phytomedicine : international …
2023
15 件の引用
Molecules (Basel, Switzerland)
2022
30 件の引用
Medicine
2022
25 件の引用
Biomedicines
2022
17 件の引用
International journal of …
2022
16 件の引用
Foods (Basel, Switzerland)
2022
14 件の引用
Biomedical reports
2022
12 件の引用
Iranian journal of …
2022
5 件の引用
Cells
2021
24 件の引用
Research in veterinary …
2021
14 件の引用
Redox biology
2020
100 件の引用
Brain and behavior
2020
45 件の引用
Potential therapeutic effect of curcumin, a natural mTOR inhibitor, in tuberous sclerosis complex.
Other
Phytomedicine : international …
2019
14 件の引用
Environmental toxicology
2017
36 件の引用
Medical science monitor …
2017
7 件の引用
Nutrients
2015
191 件の引用
BioMed research international
2014
108 件の引用
Current pharmaceutical biotechnology
2014
67 件の引用
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
一般的な使用量
- general:
- 500-2,000 mg/day of enhanced bioavailability form
- cognitivesupport:
- 90-180 mg/day Theracurmin or equivalent
上限量： Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term
研究で検討された用量
| 用量 | 期間 | 効果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| 30 ug/body, 4 injections over 30 days | 4 weeks | Positive | -- |
| 100 mg/kg each | 4 weeks | Positive | -- |
| None | -- | Mixed | -- |
| None | 8 weeks | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
推奨摂取タイミング： With meals containing fat and black pepper (piperine) for absorption
Safety & Side Effects
報告されている副作用
- ⚠ Gastrointestinal discomfort (nausea, diarrhea)
- ⚠ Headache
- ⚠ Skin rash (rare)
- ⚠ Yellow staining of teeth with powder forms
既知の相互作用
- ● Anticoagulants (may increase bleeding risk)
- ● Antidiabetic drugs (may enhance blood sugar lowering)
- ● CYP450 substrates (may affect drug metabolism)
- ● Iron supplements (curcumin may chelate iron)
耐容上限摂取量： Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term
サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
Frequently Asked Questions
Does Curcumin help with Memory Loss?
Based on 8 studies with 600 participants, there is limited but promising evidence that Curcumin may support Memory Loss management. Our evidence grade is C (Some Evidence).
How much Curcumin should I take for Memory Loss?
Studies have used various dosages. A commonly studied range is 500-2,000 mg/day of enhanced bioavailability form. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Skin rash (rare), Yellow staining of teeth with powder forms. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Memory Loss?
We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 600 total participants. The overall direction of effect is mixed.
Related Evidence
に関する他の成分： Memory Loss
Curcumin 他の症状・状態について
References
- [1] Mohammad-Ali Bashirrohelleh et al.. Eur J Pharmacol. 2025. Curcumin-enhanced stem cell exosomes: A novel approach to modulating neuroinflammation and improving cognitive function in a rat model of Alzheimer's … doi:10.1016/j.ejphar.2025.177695 PubMed
- [2] Mahsa Yavari et al.. Nutrients. 2025. Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids. doi:10.3390/nu17071203 PubMed
- [3] Nida Rasheed et al.. Exp Gerontol. 2025. Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum chloride-induced Alzheimer's disease in aged … doi:10.1016/j.exger.2024.112659 PubMed
- [4] Claudia Jara et al.. Neurotox Res. 2025. Curcumin Improves Hippocampal Cell Bioenergetics, Redox and Inflammatory Markers, and Synaptic Proteins, Regulating Mitochondrial Calcium Homeostasis. doi:10.1007/s12640-024-00726-y PubMed
- [5] Guifei Chen et al.. Food Sci Nutr. 2025. Polyphenols and Alzheimer's Disease: A Review on Molecular and Therapeutic Insights With In Silico Support. doi:10.1002/fsn3.70496 PubMed
- [6] Eunbi Cho et al.. Biomed Pharmacother. 2025. Increases in brain catecholamine levels counteract memory deficits and reduces Aβ deposition in 5XFAD male mice. doi:10.1016/j.biopha.2025.118764 PubMed
- [7] Xiaopeng Li et al.. Neurochem Res. 2025. Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer's Disease: Insights into Molecular Mechanisms and Therapeutic Potential. doi:10.1007/s11064-025-04623-4 PubMed
- [8] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
- [9] Tiago Nicoliche et al.. Sci Rep. 2024. Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2. doi:10.1038/s41598-024-61662-7 PubMed
- [10] JinJin Pei et al.. Ageing Res Rev. 2024. Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review. doi:10.1016/j.arr.2024.102393 PubMed
- [11] Zhihan Chen et al.. Chin Med. 2024. A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer's disease based on the neuroinflammatory. doi:10.1186/s13020-024-00900-6 PubMed
- [12] Faizan Ahmad et al.. Ageing Res Rev. 2024. Evolving therapeutic interventions for the management and treatment of Alzheimer's disease. doi:10.1016/j.arr.2024.102229 PubMed
- [13] Anne Suély Pinto Savall et al.. Brain Sci. 2024. Nanoencapsulated Curcumin: Enhanced Efficacy in Reversing Memory Loss in An Alzheimer Disease Model. doi:10.3390/brainsci14020130 PubMed
- [14] Bianca Sânziana Daraban et al.. Molecules. 2024. Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems. doi:10.3390/molecules29174056 PubMed
- [15] Li Li et al.. Mini Rev Med Chem. 2024. Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease. doi:10.2174/0113895575263783231009051957 PubMed
- [16] Shakeel Ahmed Ansari et al.. Pharm Nanotechnol. 2024. Current Updates on Nanotechnology-based Drug Delivery Platforms for Treating Alzheimer's with Herbal Drugs. doi:10.2174/0122117385335626241204165702 PubMed
- [17] Yuan Chen et al.. Phytomedicine. 2023. Fucoxanthin, a marine derived carotenoid, attenuates surgery-induced cognitive impairments via activating Akt and ERK pathways in aged mice. doi:10.1016/j.phymed.2023.155043 PubMed
- [18] Haya Hussain et al.. Molecules. 2022. Attenuation of Scopolamine-Induced Amnesia via Cholinergic Modulation in Mice by Synthetic Curcumin Analogs. doi:10.3390/molecules27082468 PubMed
- [19] Xinyan Wu et al.. Medicine (Baltimore). 2022. A network pharmacology approach to identify the mechanisms and molecular targets of curcumin against Alzheimer disease. doi:10.1097/MD.0000000000030194 PubMed
- [20] Haya Hussain et al.. Biomedicines. 2022. Synthetic Mono-Carbonyl Curcumin Analogues Attenuate Oxidative Stress in Mouse Models. doi:10.3390/biomedicines10102597 PubMed
- [21] Massimiliano Cuccioloni et al.. Int J Mol Sci. 2022. Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization. doi:10.3390/ijms23158710 PubMed
- [22] Suksan Changlek et al.. Foods. 2022. Curcumin Suppresses Lead-Induced Inflammation and Memory Loss in Mouse Model and In Silico Molecular Docking. doi:10.3390/foods11060856 PubMed
- [23] Thanyaphon Phothi et al.. Biomed Rep. 2022. Effects of curcumin and γ-oryzanol solid dispersion on the brain of middle-aged rats. doi:10.3892/br.2022.1542 PubMed
- [24] Khatereh Kharazmi et al.. Iran J Med Sci. 2022. Protection against Morphine-Induced Inhibitory Avoidance Memory Impairment in Rat by Curcumin: Possible Role of Nitric Oxide/ cAMP-Response Element Binding Protein … doi:10.30476/IJMS.2022.92131.2339 PubMed
- [25] Oana M Dumitrascu et al.. Cells. 2021. Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study. doi:10.3390/cells10112926 PubMed
- [26] R L Moretti et al.. Res Vet Sci. 2021. Behavioral and morphological effects of resveratrol and curcumin in rats submitted to doxorubicin-induced cognitive impairment. doi:10.1016/j.rvsc.2021.09.009 PubMed
- [27] Margrethe A Olesen et al.. Redox Biol. 2020. Premature synaptic mitochondrial dysfunction in the hippocampus during aging contributes to memory loss. doi:10.1016/j.redox.2020.101558 PubMed
- [28] Yan Xu et al.. Brain Behav. 2020. Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disease by up-regulating SIRT1. doi:10.1002/brb3.1655 PubMed
- [29] Chu-Jen Kuo et al.. Phytomedicine. 2019. Potential therapeutic effect of curcumin, a natural mTOR inhibitor, in tuberous sclerosis complex. doi:10.1016/j.phymed.2018.09.203 PubMed
- [30] Pauline da Costa et al.. Environ Toxicol. 2017. Curcumin attenuates memory deficits and the impairment of cholinergic and purinergic signaling in rats chronically exposed to cadmium. doi:10.1002/tox.22213 PubMed
- [31] Fu-Chun Zhao et al.. Med Sci Monit. 2017. Design and Development of a Novel Chalcone Derivative as an Anticholinesterase Inhibitor for Possible Treatment of Dementia. doi:10.12659/msm.901842 PubMed
- [32] Jessica E Beilharz et al.. Nutrients. 2015. Diet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional Interventions. doi:10.3390/nu7085307 PubMed
- [33] Christopher Millington et al.. Biomed Res Int. 2014. Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs. doi:10.1155/2014/309129 PubMed
- [34] D Sheeja Malar et al.. Curr Pharm Biotechnol. 2014. Dietary polyphenols for treatment of Alzheimer's disease--future research and development. doi:10.2174/1389201015666140813122703 PubMed
FDAに関する免責事項: これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。